help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mishra, A.
Right arrow Articles by Martin, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mishra, A.
Right arrow Articles by Martin, W. J., II

Am. J. Respir. Cell Mol. Biol., Volume 22, Number 5, May, 2000 543-549

Bleomycin-Mediated Pulmonary Toxicity
Evidence for a p53-Mediated Response

Anil Mishra, Nicholas A. Doyle, and William J. Martin II

Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana

Bleomycin damages DNA and causes lung injury and fibrosis. To determine whether bleomycin is associated with the appearance of DNA damage-inducible proteins, C3H mice received either 0.4 mg bleomycin or normal saline intratracheally and were killed 1 to 14 d later. The lungs were examined for expression of p53, p21WAF1/PiCl, and proliferating cell nuclear antigen (PCNA) using immunohistochemistry and Western blotting. p53-positive cells first appeared at 5 d after treatment and peaked at 7 d; PCNA-positive cells appeared at 1 d after treatment and peaked at 7 d; and p21-positive cells appeared at 5 d and peaked at 9 d. Western blot analysis confirmed that bleomycin upregulated the DNA damage-inducible proteins in a similar fashion. This is the first evidence that bleomycin causes a p53-dependent response associated with acute injury in the lung.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Shetty, J. Padijnayayveetil, T. Tucker, D. Stankowska, and S. Idell
The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L967 - L975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Shetty, P. Shetty, S. Idell, T. Velusamy, Y. P. Bhandary, and R. S. Shetty
Regulation of Plasminogen Activator Inhibitor-1 Expression by Tumor Suppressor Protein p53
J. Biol. Chem., July 11, 2008; 283(28): 19570 - 19580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Yamasaki, H.-R. Kang, R. J. Homer, S. P. Chapoval, S. J. Cho, B. J. Lee, J. A. Elias, and C. G. Lee
P21 Regulates TGF-{beta}1-Induced Pulmonary Responses via a TNF-{alpha}-Signaling Pathway
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Shetty, T. Velusamy, S. Idell, P. Shetty, A. P. Mazar, Y. P. Bhandary, and R. S. Shetty
Regulation of Urokinase Receptor Expression by p53: Novel Role in Stabilization of uPAR mRNA
Mol. Cell. Biol., August 15, 2007; 27(16): 5607 - 5618.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Inoshima, K. Kuwano, N. Hamada, M. Yoshimi, T. Maeyama, N. Hagimoto, Y. Nakanishi, and N. Hara
Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L727 - L733.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Shan, J. Xu, Y. Zhuo, C. A. Morris, and G. F. Morris
Induction of p53-dependent Activation of the Human Proliferating Cell Nuclear Antigen Gene in Chromatin by Ionizing Radiation
J. Biol. Chem., November 7, 2003; 278(45): 44009 - 44017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. J. Staversky, R. H. Watkins, T. W. Wright, E. Hernady, M. B. LoMonaco, C. T. D'Angio, J. P. Williams, W. M. Maniscalco, and M. A. O'Reilly
Normal Remodeling of the Oxygen-Injured Lung Requires the Cyclin-Dependent Kinase Inhibitor p21Cip1/WAF1/Sdi1
Am. J. Pathol., October 1, 2002; 161(4): 1383 - 1393.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Ghosh, T. Mendoza, L. A. Ortiz, G. W. Hoyle, C. D. Fermin, A. R. Brody, M. Friedman, and G. F. Morris
Bleomycin Sensitivity of Mice Expressing Dominant-Negative p53 in the Lung Epithelium
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 890 - 897.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Wu, Y.-H. He, M. Kobune, Y. Xu, M. R. Kelley, and W. J. Martin II
Protection of Human Lung Cells against Hyperoxia Using the DNA Base Excision Repair Genes hOgg1 and Fpg
Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Huang, G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros
Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L94 - L102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y.-H. He, M. Wu, M. Kobune, Y. Xu, M. R. Kelley, and W. J. Martin II
Expression of Yeast Apurinic/Apyrimidinic Endonuclease (APN1) Protects Lung Epithelial Cells From Bleomycin Toxicity
Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 692 - 698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. A. O'Reilly, R. J. Staversky, R. H. Watkins, C. K. Reed, K. L. de Mesy Jensen, J. N. Finkelstein, and P. C. Keng
The Cyclin-Dependent Kinase Inhibitor p21 Protects the Lung from Oxidative Stress
Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 703 - 710.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J.A. D. Cooper Jr.
Pulmonary Fibrosis . Pathways Are Slowly Coming into Light
Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 520 - 523.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.